期刊文献+

Roux-en-Y胃旁路术缓解2型糖尿病GK大鼠肝脏胰岛素抵抗的机制 被引量:2

Gastric Bypass Surgery Ameliorates Insulin Resistance in the Liver of Goto-Kakizaki Rats
下载PDF
导出
摘要 目的研究Roux-en-Y胃旁路术(RYGB)后GK大鼠肝脏胰岛素抵抗缓解的机制。方法 10只GK大鼠行RYGB(RYGB组),10只GK大鼠(GK组)和10只Wistar大鼠(WIS组)行假手术,检测RYGB手术前后大鼠体质量、空腹血糖、胰岛素抵抗指数的变化,检测手术前后大鼠血浆脂联素、肝细胞脂联素受体2、肝细胞内腺苷酸活化蛋白激酶(AMPK)、胰岛素受体底物2(IRS-2)的变化。结果术前RYGB组与GK组大鼠存在明显的胰岛素抵抗,RYGB组术后血糖、胰岛素抵抗指数(HOMA-IR)基本恢复至正常水平,血浆脂联素水平升高。与WIS组比较,RYGB组大鼠肝细胞的AMPKα2 mRNA水平上调1.81倍(P<0.05),IRS-2 mRNA水平上调3.24倍(P<0.05)。结论 RYGB后脂联素升高,通过脂联素受体作用于AMPK信号通路,增加葡萄糖利用,减少肝糖原异生,并通过上调IRS-2达到缓解胰岛素抵抗的作用。 Objective To explore the mechanism of gastric bypass surgery ameliorating insulin resistance in the liver of GK rats.Methods Twenty GK rats were allocated into two groups in random,the RYGB group and GK group,and another ten Wistar rats in WIS group.RYGB operation was performed on RYGB group,and Sham operation on GK group and WIS group.Body weight,blood glucose,HOMA-IR,and plasma adiponectin were measured after operation,respectively.To disclose the effect of adiponectin,the expression of AdipoR2,IRS-2,AMPK were measured after operation,respectively.Results Blood glucose was normalized and serum insulin level was reduced in RYGB group.Plasma adiponectin concentration was elevated after the operation.AMPKα2 mRNA was up-regulated 1.81 fold(P 〈 0.05) and IRS-2 mRNA was up-regulated 3.24 fold(P 〈 0.05) in RYGB group and GK group,respectively.Conclusion RYGB can down regulate hyperglycemia and reverse insulin resistance in GK rats.Adiponectin can act on AdipoR2,IRS-2,AMPK and ameliorate insulin resistance after RYGB in the liver of GK rats.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2012年第4期293-296,共4页 Journal of China Medical University
基金 国家自然科学基金青年科学基金资助项目(81000158)
关键词 ROUX-EN-Y胃旁路术 2型糖尿病 脂联素 脂联素受体2 Roux-en-Y gastric bypass diabetes mellitus adiponectin adiponectin receptors
  • 相关文献

参考文献15

  • 1Meetoo D,Mcgovern P,Safadi R. An epidemiological overview of diabetes across the world[J].British Journal of Nursing,2007,(16):1002-1007.
  • 2Vanni E,Bugianesi E,Kotronen A. From the metabolic syndrome to NAFLD or vice versa[J].Digestive and Liver Disease,2010,(05):320-330.
  • 3Bloomgarden ZT. Definitions of the insulin resistance syndrome:the 1st World Congress on the Insulin Resistance Syndrome[J].Diabetes Care,2004,(03):824-830.
  • 4Rubino F,Gagner M,Gentileschi P. The early effect of the Boux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism[J].Annals of Surgery,2004,(02):236-242.
  • 5Trakhtenbroit MA,Leichman JG,Algahim MF. Body weight,insulin resistance,and serum adipokine levels 2 years after 2 types of bariatric surgery[J].American Journal of Medicine,2009,(05):435-442.
  • 6Fang X,Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes[J].Biochemical Society Transactions,2006,(05):798-801.
  • 7Ursavas A,Ilcol YO,Nalci N. Ghrelin,leptin,ediponectin,and resistin levels in sleep apnea syndrome:role of obesity[J].Ann Thorac Med,2010,(03):161-166.
  • 8Kadowaki T. Adiponectin and adiponectin receptors in insulin resistance,diabetes,and the metabolic syndrome[J].Journal of Clinical Investigation,2006,(07):1784-1792.
  • 9Bauche IB,Aitel Mkadem S,Rezsohazy R. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice[J].Biochemical and Biophysical Research Communications,2006,(04):1414-1424.doi:10.1016/j.bbrc.2006.05.033.
  • 10Linscheid P,Christ-Crain M,Stoeckli R. Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss[J].Diabetes,Obesity and Metabolism,2008,(12):1266-1270.

同被引文献29

  • 1宋静,贾伟平,陆俊茜,陆惠娟,潘小平,项坤三.高脂饮食对Wistar和GK大鼠糖脂代谢及胰岛素分泌功能的影响[J].上海交通大学学报(医学版),2007,27(7):777-780. 被引量:5
  • 2钱一欣(综述),倪兆慧(审校).GK大鼠模型与糖尿病肾病[J].国际泌尿系统杂志,2007,27(5):715-719. 被引量:2
  • 3Amos AF, McCarty DJ, Zimmet P. The rising global burden of dia- betes and its complications: estimates and projections to the year 2010[J]. Diabet Med, 1997, 14(Suppl5): S1- S85.
  • 4van Dieren S, Beulens JW, van der Schouw YT, et al. The global burden of diabetes and its complications: an emerging pandemic [J]. Eur J Cardiovasc Prey Rebabil, 2010, 17 (Suppl 1 ) : S3 -S8.
  • 5Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunc- tion during progression to diabetes[ J ]. Diabetes, 2004, 53 (Suppl 3): S16 - S21.
  • 6Cummings DE, Flum DR. Gastrointestinal surgery as a treatment for diabetes[J]. JAMA, 2008, 299(3): 341 -343.
  • 7Ferehak CV, Meneghini LF. Obesity, bariatrie surgery and type 2 diabetes - a systematic review[ J]. Diabetes Metab Res Rev, 2004, 20(6) : 438 -445.
  • 8Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopanereatic diversion in patients with morbid obesity[J]. ObesSurg, 2007, 17(2): 176-184.
  • 9Wiekremesekera K, Miller G, Naotunne TD, et al. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study[J]. ObesSurg, 2005, 15(4): 474 -481.
  • 10Heldt CL, Sorei M, Posada D, et ai. Detection and reduction of mieroaggregates in insulin preparations [ J ]. Biotechnol Bioeng, 2011, 108(1) : 237 -241.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部